Effects of telmisartan on fat distribution in individuals with the metabolic syndrome

Visceral fat obesity plays an essential role in the clustering of atherosclerotic multiple risk factors in the metabolic syndrome. Telmisartan, an angiotensin II type 1 receptor blocker, has partial agonistic properties for peroxisome proliferator-activated receptor gamma, which is a key regulator of adipocyte differentiation and function.This study aimed to clarify the impact of telmisartan on fat distribution and insulin sensitivity in the...